The $483 million swing was largely due to an 11.6 percent increase in expenses year over year. Total revenue for 2022 was $6.6 billion, up 3.6 percent, according to a financial report from the health system.
Once one-time costs were taken into consideration — reducing leased space and a reduction in the workforce — there were signs of improved operating income in the fourth quarter compared with the previous quarter, which ended Sept. 30, the system said.
“These efforts, including the one-time reorganization costs, will generate future savings and enable MSK to continue to provide excellent patient care,” the report said.
Investment losses in the period totaled $932 million, dragging the overall loss down further. In 2021, there was a $996.7 million gain on such returns.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
